Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1911 1
1920 1
1923 2
1927 1
1936 1
1963 1
1966 2
1967 1
1969 2
1972 1
1978 1
1979 1
1980 2
1981 1
1982 6
1983 4
1984 4
1985 3
1986 1
1987 13
1988 11
1989 9
1990 10
1991 9
1992 4
1993 8
1994 15
1995 5
1996 10
1997 12
1998 5
1999 10
2000 7
2001 5
2002 9
2003 3
2004 8
2005 14
2006 21
2007 22
2008 13
2009 30
2010 30
2011 38
2012 44
2013 36
2014 61
2015 67
2016 67
2017 40
2018 49
2019 55
2020 57
2021 60
2022 54
2023 48
2024 50

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

943 results

Results by year

Filters applied: . Clear all
Page 1
Continuous vs Intermittent β-Lactam Antibiotic Infusions in Critically Ill Patients With Sepsis: The BLING III Randomized Clinical Trial.
Dulhunty JM, Brett SJ, De Waele JJ, Rajbhandari D, Billot L, Cotta MO, Davis JS, Finfer S, Hammond NE, Knowles S, Liu X, McGuinness S, Mysore J, Paterson DL, Peake S, Rhodes A, Roberts JA, Roger C, Shirwadkar C, Starr T, Taylor C, Myburgh JA, Lipman J; BLING III Study Investigators. Dulhunty JM, et al. Among authors: lipman j. JAMA. 2024 Aug 27;332(8):629-637. doi: 10.1001/jama.2024.9779. JAMA. 2024. PMID: 38864155 Free PMC article. Clinical Trial.
Prolonged vs Intermittent Infusions of β-Lactam Antibiotics in Adults With Sepsis or Septic Shock: A Systematic Review and Meta-Analysis.
Abdul-Aziz MH, Hammond NE, Brett SJ, Cotta MO, De Waele JJ, Devaux A, Di Tanna GL, Dulhunty JM, Elkady H, Eriksson L, Hasan MS, Khan AB, Lipman J, Liu X, Monti G, Myburgh J, Novy E, Omar S, Rajbhandari D, Roger C, Sjövall F, Zaghi I, Zangrillo A, Delaney A, Roberts JA. Abdul-Aziz MH, et al. Among authors: lipman j. JAMA. 2024 Aug 27;332(8):638-648. doi: 10.1001/jama.2024.9803. JAMA. 2024. PMID: 38864162 Free PMC article.
Initial antimicrobial management of sepsis.
Niederman MS, Baron RM, Bouadma L, Calandra T, Daneman N, DeWaele J, Kollef MH, Lipman J, Nair GB. Niederman MS, et al. Among authors: lipman j. Crit Care. 2021 Aug 26;25(1):307. doi: 10.1186/s13054-021-03736-w. Crit Care. 2021. PMID: 34446092 Free PMC article. Review.
Pulmonary infections complicating ARDS.
Luyt CE, Bouadma L, Morris AC, Dhanani JA, Kollef M, Lipman J, Martin-Loeches I, Nseir S, Ranzani OT, Roquilly A, Schmidt M, Torres A, Timsit JF. Luyt CE, et al. Among authors: lipman j. Intensive Care Med. 2020 Dec;46(12):2168-2183. doi: 10.1007/s00134-020-06292-z. Epub 2020 Nov 11. Intensive Care Med. 2020. PMID: 33175277 Free PMC article. Review.
Sepsis: frontiers in diagnosis, resuscitation and antibiotic therapy.
Perner A, Gordon AC, De Backer D, Dimopoulos G, Russell JA, Lipman J, Jensen JU, Myburgh J, Singer M, Bellomo R, Walsh T. Perner A, et al. Among authors: lipman j. Intensive Care Med. 2016 Dec;42(12):1958-1969. doi: 10.1007/s00134-016-4577-z. Epub 2016 Oct 1. Intensive Care Med. 2016. PMID: 27695884 Free article. Review.
Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions.
Roberts JA, Abdul-Aziz MH, Lipman J, Mouton JW, Vinks AA, Felton TW, Hope WW, Farkas A, Neely MN, Schentag JJ, Drusano G, Frey OR, Theuretzbacher U, Kuti JL; International Society of Anti-Infective Pharmacology and the Pharmacokinetics and Pharmacodynamics Study Group of the European Society of Clinical Microbiology and Infectious Diseases. Roberts JA, et al. Among authors: lipman j. Lancet Infect Dis. 2014 Jun;14(6):498-509. doi: 10.1016/S1473-3099(14)70036-2. Epub 2014 Apr 24. Lancet Infect Dis. 2014. PMID: 24768475 Free PMC article. Review.
Meropenem Versus Piperacillin-Tazobactam for Definitive Treatment of Bloodstream Infections Caused by AmpC β-Lactamase-Producing Enterobacter spp, Citrobacter freundii, Morganella morganii, Providencia spp, or Serratia marcescens: A Pilot Multicenter Randomized Controlled Trial (MERINO-2).
Stewart AG, Paterson DL, Young B, Lye DC, Davis JS, Schneider K, Yilmaz M, Dinleyici R, Runnegar N, Henderson A, Archuleta S, Kalimuddin S, Forde BM, Chatfield MD, Bauer MJ, Lipman J, Harris-Brown T, Harris PNA; MERINO Trial Investigators and the Australasian Society for Infectious Disease Clinical Research Network (ASID-CRN). Stewart AG, et al. Among authors: lipman j. Open Forum Infect Dis. 2021 Aug 2;8(8):ofab387. doi: 10.1093/ofid/ofab387. eCollection 2021 Aug. Open Forum Infect Dis. 2021. PMID: 34395716 Free PMC article.
943 results